-
161
Personalised transcranial magnetic stimulation for treatment-resistant depression, depression with comorbid anxiety and negative symptoms of schizophrenia: a narrative review
Published 2024-10-01“…Recent retrospective brain circuit-based analyses using lesion network mapping have suggested that a left dorsal lateral prefrontal cortex target has a higher efficacy for alleviating depression symptoms, a dorsomedial prefrontal cortex target is more effective for anxiety symptoms, and a rostromedial prefrontal cortex target is effective for schizophrenia-associated psychiatric symptoms. Nonetheless, symptom-specific brain circuit targeting has not been tested prospectively. …”
Get full text
Article -
162
Machine learning-based prediction of antipsychotic efficacy from brain gray matter structure in drug-naive first-episode schizophrenia
Published 2025-02-01“…Schizophrenia…”
Get full text
Article -
163
Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia? A systematic review and meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
164
Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
Published 2025-03-01“…Background: There are substantial sex differences in schizophrenia. However, research addressing sex differences regarding the antipsychotic effect on the immune system is lacking. …”
Get full text
Article -
165
Discrepancies between Self- and Clinical Staff Members’ Perception of Cognitive Functioning among Patients with Schizophrenia Undergoing Long-Term Hospitalization
Published 2019-01-01“…In Japan, long-term hospitalization of patients with schizophrenia is still prevalent, even though the focus of psychiatric care is shifting from hospitals to the community. …”
Get full text
Article -
166
The burden of depression, anxiety and schizophrenia among the older population in ageing and aged countries: an analysis of the Global Burden of Disease Study 2019
Published 2024-02-01“…Background Depression, anxiety and schizophrenia among older persons have become global public health challenges. …”
Get full text
Article -
167
A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome
Published 2020-01-01“…Schizophrenia is a chronic and severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behaviour. …”
Get full text
Article -
168
Efficacy of identifying Treatment-Resistant and non-Treatment-Resistant Schizophrenia using niacin skin flushing response combined with clinical feature
Published 2025-02-01“…Schizophrenia…”
Get full text
Article -
169
Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies
Published 2025-01-01“…ObjectiveThis study aimed to investigate the establishment and maintenance of a DWA between a beta version of CT-155/BI 3972080 (CT-155 beta) and adults with ENS of schizophrenia. MethodsTwo multicenter, exploratory, single-arm studies (study 1: CT-155-C-001 and study 2: CT-155-C-002) enrolled adults with schizophrenia and ENS receiving stable antipsychotic medication (≥12 weeks). …”
Get full text
Article -
170
Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy
Published 2017-01-01“…Clozapine is an atypical antipsychotic used in the treatment of refractory schizophrenia. It has a well-known side effect profile, including agranulocytosis, decreased seizure threshold, and tardive dyskinesia. …”
Get full text
Article -
171
-
172
A Case of New-Onset Obsessive-Compulsive Disorder and Schizophrenia in a 14-Year-Old Male following the COVID-19 Pandemic
Published 2023-01-01“…While there is substantial data suggesting exacerbations of OCD during the COVID-19 pandemic in the general population and a new onset of schizophrenia due to the virus itself, very little is known about the prevalence of either OCD or schizophrenia after the pandemic. …”
Get full text
Article -
173
-
174
Extent and pattern of burden of care and its associated factors among Eritrean families of persons living with schizophrenia: a cross-sectional study
Published 2016-09-01“…Purpose To assess the caregiving burden and its associated factors among Eritrean families of persons living with schizophrenia.Methods A cross-sectional study was conducted for 146 caregivers with their respective known patients with schizophrenia of Saint Mary's Neuropsychiatric National Referral Hospital (SMNNRH). …”
Get full text
Article -
175
Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia
Published 2025-01-01“…Abstract Schizophrenia (SZ) is a deleterious brain disorder characterised by its heterogeneity and complex symptomatology consisting of positive, negative and cognitive deficits. …”
Get full text
Article -
176
I tweet, therefore I am: a systematic review on social media use and disorders of the social brain
Published 2025-02-01Subjects: Get full text
Article -
177
Oxytocin in the Treatment of Psychiatric Disorders
Published 2023-09-01Subjects: Get full text
Article -
178
Phenome-wide association studies between SERINC2 and neuropsychiatric disorders
Published 2025-01-01Subjects: Get full text
Article -
179
The mirror preference test: A reverse translational approach to study anomalous subjective experience in rats
Published 2025-03-01Subjects: Get full text
Article -
180